Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Up-regulates Interleukin-6 in Cancer Cells and Induces Subsequent Development of Interstitial Pneumonia

Acute interstitial pneumonia is one of serious side effects of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment, while it often has significant clinical benefit in cancer patients. Therefore, it is necessary to clarify underlying mechanisms for the development of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiguro, Yukari, Ishiguro, Hitoshi, Miyamoto, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720603/
https://www.ncbi.nlm.nih.gov/pubmed/23592411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720603/
https://www.ncbi.nlm.nih.gov/pubmed/23592411

Ejemplares similares